CollPlant Biotechnologies Ltd Quarterly Cost of Revenue in USD from Q2 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
CollPlant Biotechnologies Ltd annual/quarterly Cost of Revenue history and growth rate from Q2 2019 to Q2 2024.
  • CollPlant Biotechnologies Ltd Cost of Revenue for the quarter ending June 30, 2024 was $536K, a 12.8% decline year-over-year.
  • CollPlant Biotechnologies Ltd annual Cost of Revenue for 2024 was $1.63M, a 18.4% decline from 2023.
  • CollPlant Biotechnologies Ltd annual Cost of Revenue for 2023 was $1.99M, a 398% increase from 2022.
  • CollPlant Biotechnologies Ltd annual Cost of Revenue for 2022 was $400K, a 80.1% decline from 2021.
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $536K -$79K -12.8% Apr 1, 2024 Jun 30, 2024 6-K 2024-08-20
Q2 2023 $615K +$572K +1330% Apr 1, 2023 Jun 30, 2023 6-K 2024-08-20
Q2 2022 $43K -$386K -90% Apr 1, 2022 Jun 30, 2022 6-K 2023-08-24
Q2 2021 $429K -$319K -42.6% Apr 1, 2021 Jun 30, 2021 6-K 2022-08-25
Q2 2020 $748K +$285K +61.6% Apr 1, 2020 Jun 30, 2020 6-K 2021-08-19
Q2 2019 $463K Apr 1, 2019 Jun 30, 2019 6-K 2020-08-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.